StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Entresto Global Growth in Constant Currencies by Year

Entresto Global Growth in Constant Currencies (% cc) (%)

Novartis Entresto Global Growth in Constant Currencies: -2.0% in FY2025, down 33.0 pts from a year earlier. That is the lowest of the 8 years on record here.

Latest, FY2025
-2.0%
Period ended Dec 31, 2025
Change on a year earlier
-33.0 pts
31.0% in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below

Where the FY2025 figure comes from

“|| Entresto | 7 748 | 7 822 | -1 | -2”

Source: Novartis Form 6-K (0001114448-26-000007) ↗

Reported in Form 6-K & Form 20-F.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEntresto Global Growth in Constant Currencies (% cc) (%)Year on yearSource
FY2025Dec 31, 2025-2.0%-33.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
FY2024Dec 31, 202431.0%0.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
FY2023Dec 31, 202331.0%-6.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
FY2022Dec 31, 202237.0%-3.0 ptsNovartis Form 6-K (0001370368-23-000008) ↗
FY2021Dec 31, 202140.0%-4.0 ptsNovartis Form 6-K (0001370368-22-000009) ↗
FY2020Dec 31, 202044.0%-27.0 ptsNovartis Form 6-K (0001370368-21-000008) ↗
FY2019Dec 31, 201971.0%-31.0 ptsNovartis Form 6-K (0001370368-20-000007) ↗
FY2018Dec 31, 2018102.0%–Novartis Form 6-K (0001370368-19-000006) ↗

Cite this data

StockData. (2026). Novartis Entresto Global Growth in Constant Currencies (%), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-entresto-yoy-cc-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.